H. Jefferson Leighton
Vorstandsvorsitzender bei BioDesign, Inc.
Profil
H.
Jefferson Leighton is the founder of Inspire Pharmaceuticals, Inc. (1993), AdipoGenix, Inc. (1997), and BioDesign, Inc. (1997).
At BioDesign, Inc., he holds the title of Chief Executive Officer.
Dr. Leighton is also the founder of Neusentis, Inc. Dr. Leighton's former jobs include Director at Adenosine Therapeutics LLC, Chief Scientific Officer at Milestone Pharmaceuticals, Inc., Executive Vice President-Research & Development at Sphinx Pharmaceuticals Corp, and Advisor at Echelon Ventures.
He was also Vice President-Research at Glaxo Wellcome, Inc. from 1986 to 1991.
Dr. Leighton received a doctorate degree from the University of Virginia in 1976 and both undergraduate and graduate degrees from the University of South Carolina.
Aktive Positionen von H. Jefferson Leighton
| Unternehmen | Position | Beginn |
|---|---|---|
| BioDesign, Inc. | Vorstandsvorsitzender | 02.05.2011 |
Ehemalige bekannte Positionen von H. Jefferson Leighton
| Unternehmen | Position | Ende |
|---|---|---|
Echelon Ventures
 Echelon Ventures Investment ManagersFinance Echelon Ventures (Echelon Ventures) is a venture capital firm founded in 2000 by Woody S Woodworth and Scott C McCabe. The firm is headquartered in Waltham, Massachusetts. | Private Equity Investor | 30.08.2008 |
Neusentis, Inc.
 Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | Gründer | 15.10.2005 |
| Glaxo Wellcome, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1991 |
| Sphinx Pharmaceuticals Corp | Technik-/Wissenschafts-/F&E-Leiter | - |
Inspire Pharmaceuticals, Inc.
 Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Gründer | - |
Ausbildung von H. Jefferson Leighton
| University of Virginia | Doctorate Degree |
| University of South Carolina | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Health Technology |
AdipoGenix, Inc.
 AdipoGenix, Inc. Pharmaceuticals: MajorHealth Technology AdipoGenix, Inc. develops molecular pharmaceutical products. It offers small molecule pharmaceuticals to treat obesity and its co-morbidities. The firm’s technology includes AdipoBASE, AdipoSCREEN, AdipoPATH and AdipoTARGET. The company was founded by Gerri Waloga, Barbara E. Corkey, Stephen R. Farmer, James A. Hamilton, James L. Kirkland, H. Jeff Leighton and Paul F. Pilch in 1997 and is headquartered in Boston, MA. | Health Technology |
Neusentis, Inc.
Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | Health Technology |
Adenosine Therapeutics LLC
 Adenosine Therapeutics LLC Pharmaceuticals: MajorHealth Technology Adenosine Therapeutics LLC manufactures and develops pharmaceutical products. It provides drugs for sepsis, heart attack, vascular injury, asthma, spinal cord injury and organ transplantation. The company was founded by Joel M. Linden, George A. Beller and Robert S. Capon in 1999 and is headquartered in Charlottesville, VA. | Health Technology |
| Sphinx Pharmaceuticals Corp | Health Technology |
Echelon Ventures
Echelon Ventures Investment ManagersFinance Echelon Ventures (Echelon Ventures) is a venture capital firm founded in 2000 by Woody S Woodworth and Scott C McCabe. The firm is headquartered in Waltham, Massachusetts. | Finance |
| Glaxo Wellcome, Inc. | Health Technology |
| BioDesign, Inc. |
